Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Role of fMRI to Assess Plasticity of the Motor System in MS.
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod.
Examining vascular remodeling in the hypoxic central nervous system.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Duality of Antidepressants and Neuroprotectants.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.
Modulation of C-nociceptive Activities by Inputs from Myelinated Fibers.
Sleep Disorders in Multiple Sclerosis.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Current and Emerging Therapies for Multiple Sclerosis.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial.
Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
In silico investigation of novel biological pathways: The role of CD200 in regulation of T cell priming in experimental autoimmune encephalomyelitis.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
B Cells Fuel Inflammation in Multiple Sclerosis.
Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil.
A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations.
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
Chronic stress regulates NG2(+) cell maturation and myelination in the prefrontal cortex through induction of death receptor 6.
Pages
« first
‹ previous
…
666
667
668
669
670
671
672
673
674
…
next ›
last »